tryptophan has been researched along with Phobic Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adrover, M; Argyropoulos, SV; Bell, CJ; Hood, SD; Nash, JR; Nutt, DJ; Rich, AS; Rich, NC; Witchel, HJ | 1 |
| Hudson, C; Hudson, S; MacKenzie, J | 1 |
| Allan, T; Appeltauer, L; McClure, DJ; Pecknold, JC; Wrzesinski, L | 1 |
| Bailey, RI; Wootton, LW | 1 |
3 trial(s) available for tryptophan and Phobic Disorders
| Article | Year |
|---|---|
Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.
Topics: Adult; Anxiety; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan | 2004 |
Protein-source tryptophan as an efficacious treatment for social anxiety disorder: a pilot study.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Cucurbita; Double-Blind Method; Humans; Middle Aged; Phobic Disorders; Pilot Projects; Plant Proteins; Seeds; Social Behavior; Tryptophan | 2007 |
Does tryptophan potentiate clomipramine in the treatment of agoraphobic and social phobic patients?
Topics: Adult; Agoraphobia; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phobic Disorders; Psychiatric Status Rating Scales; Tryptophan | 1982 |
1 other study(ies) available for tryptophan and Phobic Disorders
| Article | Year |
|---|---|
Pain, depression and phobia: a biochemical hypothesis.
Topics: Adrenocorticotropic Hormone; Aged; Anti-Anxiety Agents; Antidepressive Agents; Depression; Ethanol; Female; Glucocorticoids; Glutamates; Humans; Male; Middle Aged; Norepinephrine; Pain; Phobic Disorders; Serotonin; Tryptophan | 1976 |